Good At

He is good at applying world advanced technologies such as robot-assisted laparoscopy, ordinary laparoscopy, flexible ureteroscopy/rigid ureteroscopy, percutaneous nephroscopy, holmium laser, thulium laser and semiconductor laser to treat urogenital tumors (such as prostate cancer, kidney cancer, bladder cancer, adrenal tumors, etc.), urinary stones and prostatic hyperplasia, and has accumulated rich experience in carrying out minimally invasive surgical treatment of diseases such as.

Introduction

Wu Zhong, a member of the Communist Party of China, graduated from Shanghai Medical School of Fudan University (formerly Shanghai Medical University) with a doctorate in medicine. He is currently the director of the Urology Stone Diagnosis and Treatment Center of Fudan University, the administrative deputy director, professor, chief physician and doctoral supervisor of the Department of Urology, Huashan Hospital Affiliated to Fudan University. It is the first in China to carry out minimally invasive surgical treatment and research and application of new technologies for diseases such as urogenital tumors, urinary stones and prostate hyperplasia (prostate hypertrophy). Specializes in treating urogenital tumors (Prostate cancer, kidney cancer, bladder cancer, etc.), urinary stones Diagnosis and treatment of difficult and miscellaneous diseases such as complex kidney stones, ureteral stones, bladder stones, prostate hyperplasia and adrenal tumors, and is especially good at applying robot-assisted laparoscopy (Da Vinci robotic surgery), ordinary laparoscopy, flexible ureteroscopy or rigid ureteroscopy, percutaneous nephroscopy, transurethral resectoscopy, as well as holmium laser, thulium laser and dragon laser and other world advanced technologies to carry out various minimally invasive surgery in urology. The curative effect is remarkable and is well received by patients. The relevant technologies have reached the international advanced and domestic leading levels. He has deep attainments and accumulated rich experience in minimally invasive surgery to treat urogenital tumors, urinary stones and prostate hyperplasia. He has successively presided over research projects such as the National Natural Science Foundation of China, the 13th Five-Year Plan major special sub-projects of the Ministry of Science and Technology, the key clinical projects of the National Health Commission, the key projects of the Shanghai City Science and Technology Commission, and the Natural Science Foundation of the Shanghai City Science and Technology Commission. Participated in many top international academic conferences such as IAU, AUA, EAU, and SIU and top national academic conferences such as CUA and CUDA